ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2012

Jul 9, 2012

SEC Form 4/A — Form 4/A

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2012-02-16

Reporting Person: GIVEN BRUCE D (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-16	Stock Option dated 02/16/12	$5.19	A	110000	Acquired	2022-02-16	Common Stock (110000)	Direct

Footnotes

F1: Option vests in 48 equal monthly installments.

F2: Amended because original filing was incorrectly listed as "D" instead of "A"